Alterity obtains authorisation in Italy for Phase II trial of multiple system atrophy therapy
The randomised, double-blind, placebo-controlled trial will analyse ATH434 in early-stage MSA patients.
Central Nervous System
Latest in
Central Nervous System
The metaverse: the next frontier in clinical trials?
Digital simulation could help break down healthcare barriers, but experts caution the clinical trials sector to go slow.
By
‘How badly does it hurt?’ Challenges of measuring pain in clinical trials
Mapping Endpoints: Most clinical trials for pain still use a zero-to-ten scale as a primary endpoint. Experts are on the…
By
Integrated research organisation Centricity merges with Aventiv
Through the merger with Aventiv, Centricity now provides CROs and sponsors access to 45 clinical trial sites.
Astrocyte begins dosing in Phase I trial of traumatic brain injury therapy
The trial will evaluate multiple dose levels of AST-004 over six months at a clinical research site in Kistarcsa, Hungary.
Aural and Koneksa collaborate to use speech analytics for clinical trials
The partnership aims to easily incorporate speech measures to Koneksa studies and digital biomarker development programmes.
Alnylam reports positive Phase II immunoglobulin A nephropathy data
In the trial, cemdisiran offered a 37% mean decline from baseline in the 24-hour urine protein to creatinine ratio versus…
Pipeline Moves: Eledon’s advancement shot in ALS reviewed after Phase IIa data reveal
The Clinical Trials Arena team also dig into benign tumours, hepatitis B, lymphomas, myelofibrosis, polycythemia vera, and soft tissue sarcoma.
By